<DOC>
	<DOCNO>NCT00006020</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . PURPOSE : Phase II trial study effectiveness 506U78 treat patient recurrent refractory acute lymphocytic leukemia .</brief_summary>
	<brief_title>S0010 506U78 Treating Patients With Recurrent Refractory Acute Lymphocytic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Assess complete remission rate patient recurrent refractory non-T-cell acute lymphocytic leukemia treat 506U78 . - Determine frequency severity toxic effect drug patient . OUTLINE : This multicenter study . Patients receive 506U78 IV 2 hour day 1 , 3 , 5 . Treatment continue every 21 day 4 course absence disease progression unacceptable toxicity . Patients follow every month 6 month , every 3 month 1 year , every 6 month 3.5 year . PROJECTED ACCRUAL : A total 20-35 patient accrue study within 18 month .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute lymphocytic leukemia ( ALL ) FAB class L1L2 NonTcell ALL ( lymphocytic immunophenotype marker CD19+ , CD5 , CD7 peripheral blood , bone marrow , least 1 extramedullary disease site ) Coexpression myeloid antigens CD13 CD33 allow Histologically confirm extramedullary disease absence bone marrow blood involvement allow CD3 myeloperoxidase marker negative Meeting 1 follow criterion recurrent/refractory disease : Refractory standard induction regimen include least vincristine prednisone Recurrence response prior induction therapy Recurrence failure subsequent treatment No CNS involvement Must register SWOGS9910 SWOG9007 PATIENT CHARACTERISTICS : Age : 16 Performance status : Zubrod 03 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Bilirubin great 1.5 time upper limit normal ( ULN ) SGOT SGPT great 3 time ULN Renal : Creatinine great 2 time ULN Other : Not pregnant nursing Fertile patient must use effective contraception No grade 2 great neuropathy No prior malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer , carcinoma situ cervix , adequately treated stage I II cancer complete remission PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy See Disease Characteristics Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>recurrent adult acute lymphoblastic leukemia</keyword>
	<keyword>L1 adult acute lymphoblastic leukemia</keyword>
	<keyword>L2 adult acute lymphoblastic leukemia</keyword>
	<keyword>B-cell adult acute lymphoblastic leukemia</keyword>
	<keyword>non-T , non-B adult acute lymphoblastic leukemia</keyword>
</DOC>